144 related articles for article (PubMed ID: 37463955)
1. Effective SARS-CoV-2 replication of monolayers of intestinal epithelial cells differentiated from human induced pluripotent stem cells.
Minami S; Matsumoto N; Omori H; Nakamura Y; Tamiya S; Nouda R; Nurdin JA; Yamasaki M; Kotaki T; Kanai Y; Okamoto T; Tachibana T; Ushijima H; Kobayashi T; Sato S
Sci Rep; 2023 Jul; 13(1):11610. PubMed ID: 37463955
[TBL] [Abstract][Full Text] [Related]
2. Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection.
Wang R; Hume AJ; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Le Suer J; Huang J; Olejnik J; Villacorta-Martin C; Bullitt E; Hinds A; Ghaedi M; Rollins S; Werder RB; Abo KM; Wilson AA; Mühlberger E; Kotton DN; Hawkins FJ
Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L462-L478. PubMed ID: 35020534
[TBL] [Abstract][Full Text] [Related]
3. Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Higashi-Kuwata N; Yabe SG; Fukuda S; Nishida J; Tamura-Nakano M; Hattori SI; Okochi H; Mitsuya H
Microbiol Spectr; 2022 Dec; 10(6):e0349022. PubMed ID: 36314907
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
5. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids.
Tsai PH; Sun JR; Chien Y; Chan MS; Khor W; Yang HC; Huang CH; Hsiung CN; Hwa TY; Lin YY; Yeh CL; Wang ML; Yang YP; Chen YM; Tsai FT; Lee MS; Cheng YH; Tsai SK; Liu PC; Chou SJ; Chiou SH
J Adv Res; 2024 Jun; 60():127-140. PubMed ID: 37557954
[TBL] [Abstract][Full Text] [Related]
6. Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids.
Tiwari SK; Wang S; Smith D; Carlin AF; Rana TM
Stem Cell Reports; 2021 Mar; 16(3):437-445. PubMed ID: 33631122
[TBL] [Abstract][Full Text] [Related]
7. Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response.
Mithal A; Hume AJ; Lindstrom-Vautrin J; Villacorta-Martin C; Olejnik J; Bullitt E; Hinds A; Mühlberger E; Mostoslavsky G
Stem Cell Reports; 2021 Apr; 16(4):940-953. PubMed ID: 33852884
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.
Yamada S; Noda T; Okabe K; Yanagida S; Nishida M; Kanda Y
J Pharmacol Sci; 2022 Jul; 149(3):139-146. PubMed ID: 35641026
[TBL] [Abstract][Full Text] [Related]
9. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
10. The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.
Gandikota C; Vaddadi K; Sivasami P; Huang C; Liang Y; Pushparaj S; Deng X; Channappanava R; Metcalf JP; Liu L
J Med Virol; 2024 Apr; 96(4):e29579. PubMed ID: 38572923
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
[TBL] [Abstract][Full Text] [Related]
12. Topical TMPRSS2 inhibition prevents SARS-CoV-2 infection in differentiated human airway cultures.
Guo W; Porter LM; Crozier TW; Coates M; Jha A; McKie M; Nathan JA; Lehner PJ; Greenwood EJ; McCaughan F
Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 35110354
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids
Kim MJ; Kim S; Kim H; Gil D; Han HJ; Thimmulappa RK; Choi JH; Kim JH
Emerg Microbes Infect; 2023 Dec; 12(1):2211685. PubMed ID: 37161660
[TBL] [Abstract][Full Text] [Related]
14. Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection.
Jang KK; Kaczmarek ME; Dallari S; Chen YH; Tada T; Axelrad J; Landau NR; Stapleford KA; Cadwell K
PLoS Biol; 2022 Mar; 20(3):e3001592. PubMed ID: 35358182
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 research using human pluripotent stem cells and organoids.
Deguchi S; Serrano-Aroca Á; Tambuwala MM; Uhal BD; Brufsky AM; Takayama K
Stem Cells Transl Med; 2021 Nov; 10(11):1491-1499. PubMed ID: 34302450
[TBL] [Abstract][Full Text] [Related]
16. Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
Lee CY; Huang CH; Rastegari E; Rengganaten V; Liu PC; Tsai PH; Chin YF; Wu JR; Chiou SH; Teng YC; Lee CW; Liang Y; Chen AY; Hsu SC; Hung YJ; Sun JR; Chien CS; Chien Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576032
[TBL] [Abstract][Full Text] [Related]
17. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
18. Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing.
Tsuji K; Yamada S; Hirai K; Asakura H; Kanda Y
J Toxicol Sci; 2021; 46(9):425-435. PubMed ID: 34470994
[TBL] [Abstract][Full Text] [Related]
19. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.
Mahalingam R; Dharmalingam P; Santhanam A; Kotla S; Davuluri G; Karmouty-Quintana H; Ashrith G; Thandavarayan RA
J Cell Physiol; 2021 Apr; 236(4):2950-2958. PubMed ID: 32944935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
